Anti-IL6 and Corticosteroid Monotherapy vs Combination in COVID-19

NCT04486521 · clinicaltrials.gov ↗

UNKNOWN

Status

860

Enrollment

OTHER

Sponsor class

Conditions

Critical Illness
Corona Virus Infection
Cytokine Release Syndrome

Interventions

DRUG: Interleukin 6 (IL6) Antagonist
DRUG: Interleukin 6 (IL6) Antagonist and corticosteroids
DRUG: corticosteroid alone

Sponsor

King Faisal Specialist Hospital & Research Center

Collaborators

[object Object]